Reckitt Benckiser Group (LON:RB) has been assigned a GBX 8,000 ($104.52) price target by equities researchers at UBS Group in a report issued on Friday, Borsen Zeitung reports.
RB has been the topic of a number of other reports. Jefferies Financial Group set a GBX 5,700 ($74.47) price objective on Reckitt Benckiser Group in a research report on Thursday. JPMorgan Chase & Co. set a GBX 8,500 ($111.05) target price on shares of Reckitt Benckiser Group in a research report on Thursday. Barclays set a GBX 9,500 ($124.12) price target on shares of Reckitt Benckiser Group in a research note on Monday, September 20th. The Goldman Sachs Group set a GBX 6,000 ($78.39) price objective on Reckitt Benckiser Group in a research report on Friday. Finally, Berenberg Bank set a GBX 7,870 ($102.82) price target on Reckitt Benckiser Group in a research report on Wednesday, July 28th. Four investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of GBX 7,197.27 ($94.03).
The company has a debt-to-equity ratio of 116.01, a quick ratio of 0.53 and a current ratio of 0.77. The firm has a 50-day moving average of GBX 6,356.14. The firm has a market capitalization of £48.36 billion and a P/E ratio of 40.79. Reckitt Benckiser Group has a 1 year low of GBX 5,782 ($75.54) and a 1 year high of GBX 8,020 ($104.78).
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Article: Return on Equity (ROE)
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.